Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors

التفاصيل البيبلوغرافية
العنوان: Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors
المؤلفون: Yee Hwa Wong, CongBao Kang, Xiaoying Koh-Stenta, Alex Matter, Wenhe Zhong, Hui Qi Ng, Klement Foo, Megan E. McBee, Ann Koay, Anders Poulsen, Julien Lescar, Jeffrey Hill, Abbas El Sahili, Qianhui Nah, Yan Li, Yok Hian Chionh, Anna Ngo, Meng Ling Choong, Peter C. Dedon
المساهمون: School of Biological Sciences, NTU Institute of Structural Biology, Singapore-MIT Alliance for Research and Technology
المصدر: ACS Infectious Diseases. 5:326-335
بيانات النشر: American Chemical Society (ACS), 2019.
سنة النشر: 2019
مصطلحات موضوعية: 0301 basic medicine, TRNA modification, Methyltransferase, biology, Chemistry, High-throughput screening, 030106 microbiology, Biological sciences [Science], tRNA Modification, biology.organism_classification, 03 medical and health sciences, 030104 developmental biology, Infectious Diseases, Biochemistry, Enzyme inhibitor, High-throughput Screening, Transfer RNA, biology.protein, Transferase, Antibacterial activity, Bacteria
الوصف: Bacterial tRNA modification synthesis pathways are critical to cell survival under stress and thus represent ideal mechanism-based targets for antibiotic development. One such target is the tRNA-(N1G37) methyltransferase (TrmD), which is conserved and essential in many bacterial pathogens. Here we developed and applied a widely applicable, radioactivity-free, bioluminescence-based high-throughput screen (HTS) against 116350 compounds from structurally diverse small-molecule libraries to identify inhibitors of Pseudomonas aeruginosa TrmD ( PaTrmD). Of 285 compounds passing primary and secondary screens, a total of 61 TrmD inhibitors comprised of more than 12 different chemical scaffolds were identified, all showing submicromolar to low micromolar enzyme inhibitor constants, with binding affinity confirmed by thermal stability and surface plasmon resonance. S-Adenosyl-l-methionine (SAM) competition assays suggested that compounds in the pyridine-pyrazole-piperidine scaffold were substrate SAM-competitive inhibitors. This was confirmed in structural studies, with nuclear magnetic resonance analysis and crystal structures of PaTrmD showing pyridine-pyrazole-piperidine compounds bound in the SAM-binding pocket. Five hits showed cellular activities against Gram-positive bacteria, including mycobacteria, while one compound, a SAM-noncompetitive inhibitor, exhibited broad-spectrum antibacterial activity. The results of this HTS expand the repertoire of TrmD-inhibiting molecular scaffolds that show promise for antibiotic development. Agency for Science, Technology and Research (A*STAR) Ministry of Education (MOE) National Research Foundation (NRF) Singapore-MIT Alliance for Research and Technology (SMART) Published version This research was supported by the National Research Foundation of Singapore through the Singapore-MIT Alliance for Research and Technology (SMART) Infectious Diseases and Antimicrobial Resistance Interdisciplinary Research Groups; SMART Innovation Centre Grant ING137070-BIO to P.D. and J.L.; the Biomedical Sciences Institutes (BMSI), Agency for Science, Technology, and Research (A*STAR), Singapore; and AcRF Grants Tier1 RG154/14 and MOE2015- T2-2-075 to J.L.
وصف الملف: application/pdf
تدمد: 2373-8227
DOI: 10.1021/acsinfecdis.8b00275
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba136b2d4dbc1e07c0350f39a81a8c5
https://doi.org/10.1021/acsinfecdis.8b00275
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....1ba136b2d4dbc1e07c0350f39a81a8c5
قاعدة البيانات: OpenAIRE